Underuse of breast cancer adjuvant treatment: patient knowledge, beliefs, and medical mistrust
- PMID: 19770368
- PMCID: PMC2773474
- DOI: 10.1200/JCO.2009.22.9773
Underuse of breast cancer adjuvant treatment: patient knowledge, beliefs, and medical mistrust
Abstract
Purpose: Little is known about why women with breast cancer who have surgery do not receive proven effective postsurgical adjuvant treatments.
Methods: We surveyed 258 women who recently underwent surgical treatment at six New York City hospitals for early-stage breast cancer about their care, knowledge, and beliefs about breast cancer and its treatment. As per national guidelines, all women should have received adjuvant treatment. Adjuvant treatment data were obtained from inpatient and outpatient charts. Factor analysis was used to create scales scored to 100 of treatment beliefs and knowledge, medical mistrust, and physician communication about treatment. Bivariate and multivariate analyses assessed differences between treated and untreated women.
Results: Compared with treated women, untreated women were less likely to know that adjuvant therapies increase survival (on a 100-point scale; 66 v 75; P < .0001), had greater mistrust (64 v 53; P = .001), and had less self-efficacy (92 v 97; P < .05); physician communication about treatment did not affect patient knowledge of treatment benefits (r = 0.8; P = .21). Multivariate analysis found that untreated women were more likely to be 70 years or older (adjusted relative risk [aRR], 1.11; 95% CI, 1.00 to 1.13), to have comorbidities (aRR, 1.10; 95% CI, 1.04 to 1.12), and to express mistrust in the medical delivery system (aRR, 1.003; 95% CI, 1.00 to 1.007), even though they were more likely to believe adjuvant treatments were beneficial (aRR, 0.99; 95% CI, 0.98 to 0.99; model c, 0.84; P < or = .0001).
Conclusion: Patient knowledge and beliefs about treatment and medical mistrust are mutable factors associated with underuse of effective adjuvant therapies. Physicians may improve cancer care by ensuring that discussions about adjuvant therapy include a clear presentation of the benefits, not just the risks of treatment, and by addressing patient trust in and concerns about the medical system.
Conflict of interest statement
Authors' disclosures of potential conflicts of interest and author contributions are found at the end of this article.
Similar articles
-
A tracking and feedback registry to reduce racial disparities in breast cancer care.J Natl Cancer Inst. 2008 Dec 3;100(23):1717-23. doi: 10.1093/jnci/djn387. Epub 2008 Nov 25. J Natl Cancer Inst. 2008. PMID: 19033569 Free PMC article.
-
Physicians' reasons for failing to deliver effective breast cancer care: a framework for underuse.Med Care. 2003 Mar;41(3):442-6. doi: 10.1097/01.MLR.0000052978.49993.27. Med Care. 2003. PMID: 12618647
-
Lost opportunities: physicians' reasons and disparities in breast cancer treatment.J Clin Oncol. 2007 Jun 20;25(18):2516-21. doi: 10.1200/JCO.2006.09.5539. J Clin Oncol. 2007. PMID: 17577028
-
Factors influencing treatment patterns of breast cancer patients age 75 and older.Crit Rev Oncol Hematol. 2003 May;46(2):121-6. doi: 10.1016/s1040-8428(02)00133-6. Crit Rev Oncol Hematol. 2003. PMID: 12711357 Review.
-
[Effective treatment strategy in elderly breast cancer patients].Orv Hetil. 2005 Jan 2;146(1):15-21. Orv Hetil. 2005. PMID: 15715368 Review. Hungarian.
Cited by
-
The Encounter of Two Worlds: Divided Narratives of Decision-Making on Cancer Treatment Between Physicians and Patients.Health Expect. 2024 Oct;27(5):e70029. doi: 10.1111/hex.70029. Health Expect. 2024. PMID: 39358983 Free PMC article.
-
Associations Between Perceived Discrimination, Screening Mammography, and Breast Cancer Stage at Diagnosis: A Prospective Cohort Analysis.Ann Surg Oncol. 2024 Nov;31(12):8012-8020. doi: 10.1245/s10434-024-15757-0. Epub 2024 Jul 26. Ann Surg Oncol. 2024. PMID: 39060693 Free PMC article.
-
Racial discrimination and healthcare system trust among American adults with and without cancer.J Natl Cancer Inst. 2024 Jun 27:djae154. doi: 10.1093/jnci/djae154. Online ahead of print. J Natl Cancer Inst. 2024. PMID: 38937274
-
"Should I Prioritize My Cancer or My Diabetes?": Patient-Perceived Barriers to Co-Managing Cancer and Diabetes Mellitus.J Cancer Educ. 2024 Aug;39(4):437-444. doi: 10.1007/s13187-024-02425-w. Epub 2024 Apr 20. J Cancer Educ. 2024. PMID: 38642287
-
Simulating the population impact of interventions to reduce racial gaps in breast cancer treatment.J Natl Cancer Inst. 2024 Jun 7;116(6):902-910. doi: 10.1093/jnci/djae019. J Natl Cancer Inst. 2024. PMID: 38281076
References
-
- Bickell NA, Wang JJ, Oluwole S, et al. Missed opportunities: Racial disparities in adjuvant breast cancer treatment. J Clin Oncol. 2006;24:1357–1362. - PubMed
-
- Haggstrom DA, Quale C, Smith-Bindman R. Differences in the quality of breast cancer care among vulnerable populations. Cancer. 2005;104:2347–2358. - PubMed
-
- Shavers VL, Harlan LC, Stevens JL. Racial/ethnic variation in clinical presentation, treatment, and survival among breast cancer patients under age 35. Cancer. 2003;97:134–147. - PubMed
-
- Bickell NA, LePar F, Wang JJ, et al. Lost opportunities: Physicians' reasons and disparities in breast cancer treatment. J Clin Oncol. 2007;25:2516–2521. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials
